Menu

Welcome to the European Association for Cancer Research
Europe’s membership association for cancer researchers

Radiation Break-through: from DNA damage responses to precision cancer therapy

Oxford, UK : 12 - 14 March 2018

Introduction

The DNA damage response is critical to the maintenance of the genome and also determines the efficacy of DNA-damaging cancer therapies including radiotherapy and chemotherapy. Aberrant DNA damage response and DNA repair are frequent in malignant tumours and can sustain tumour development. At the same time, they offer tumour-specific vulnerabilities that can be exploited in the clinic. Understanding how the DNA damage response is regulated by genetic or metabolic alterations and microenvironmental cues is thus crucial to the design of therapeutic strategies based DNA damage induction, photon and particle irradiation, as well as to minimizing resistance to radiotherapy and chemotherapy. It is an exciting and rapidly evolving research field that will expedite the development and implementation of biomarkers for patient stratification and of novel treatment concepts in precision cancer medicine.

This is the second EACR conference focused on this topic. It is designed to be of interest to cancer scientists and medical oncologists with expertise in basic, translational and clinical research. Its objective is to cover recent and exciting developments in the field that are crucial to our understanding of the multifaceted role of the DNA damage response and associated tumour cell specific alterations in cancer initiation, progression and precision cancer therapy.

Target audience

This EACR conference aims to bring together cancer scientists and physicians from different disciplines with an interest in DNA damage signalling and repair, the response of cells and tissues to photon and proton irradiation, as well as related fields of cancer research spanning from basic to clinical research. We envision ample opportunities for early stage basic cancer researchers and young physicians to present their work to the international community and to meet experts in the field in an inspiring informal atmosphere to share research findings and to establish or strengthen collaborations.

Topics to be covered

  • Mechanistic insights into the cellular responses to DNA damage and genomic stability
  • Therapeutic exploitation of defective DNA damage response and repair
  • New treatment approaches combining radiotherapy with targeted drugs or immunotherapy
  • Radiobiology biomarkers for precision radiotherapy

Scientific Programme Committee: Verena Jendrossek (Germany), Martin Pruschy (Switzerland) and Madalena Tarsounas (UK)

 

This conference has been certified compliant with the MedTech Europe Code of Ethical Business Practice 

Key dates

Bursary application deadline:
15 January 2018

Abstract submission deadline:
15 January 2018

Registration deadline:
12 February 2018

Venue

Wolfson College, a modern college next to the River Cherwell.

Sorry. You need to upgrade your browser

You are using Internet Explorer 8

This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.

Thank you.